You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GRCE Buy Disclosure
Kohli Prashant · SEC Form 4 · Filed Sep 10, 2026
Buy
Calculated transaction value
$214K
Kohli Prashant Chief Executive Officer
GRCE
Grace Therapeutics
GRCE
Transaction date
Sep 9, 2026
Public filing date
Sep 10, 2026
Filing lag
Filed 1 day later
GRCE daily price context
Close on/before transaction
$2.14
Sep 9, 2026
First close after public filing
$2.26
Sep 10, 2026
30-day return after filing
-10.62%
Through Oct 12, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 100,000 shares @ $2.14
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001140361-26-036125
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$214K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Grace Therapeutics, Inc. GRCE Current | Buy | Sep 9, 2026 | $214K |